UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 ~~under the Securities Exchange Act of 1934~~

~~For~~under the ~~month~~Securities ofExchange ~~March~~Act ~~2018~~of 1934

For the month of April 2018

Lombard Medical, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Commission File Number 001-36402

N/A

(Translation of Registrant’s Name into English)

Cayman Islands (State or Other Jurisdiction of Incorporation or Organization) 3841 (Primary Standard Industrial Classification Code Number) Not applicable (I.R.S. Employer Identification Number)

Cayman Islands

3841

Not applicable

(State or Other Jurisdiction of

Incorporation or Organization)

(Primary Standard Industrial

Classification Code Number)

(I.R.S. Employer

Identification Number)

Lombard Medical House

4 Trident Park

Didcot

Oxfordshire OX11 7HJ

+44-1235-750849

(Address, Including ZIP Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

~~Entry~~On ~~Into~~April 24, 2015, Lombard Medical, Inc. (the “Company”) entered into a ~~Material~~loan ~~Definitive~~and security ~~Agreements~~agreement (as amended, the “Loan Agreement”), by and among the Company, Oxford Finance LLC (“Oxford Finance”), as collateral agent and one of the lenders thereunder, the other lenders listed therein and Lombard Medical Technologies Inc., a Delaware corporation (“LM Technologies”) and Altura Medical, Inc., a Delaware corporation (“Altura”). Both LM Technologies and Altura are indirect subsidiaries of the Company and the “Borrowers” under the Loan Agreement and the Company is a guarantor of the loan under the Loan Agreement (the “Loan”). The Loan was secured by substantially all of the assets of the Borrowers and the Company.

OnAs ~~January 31,~~previously ~~2018 and February 28~~disclosed, ~~2018,~~the ~~Lombard~~Loan ~~Medical~~Agreement, ~~Inc.~~as ~~(the~~amended ~~“Company”)~~through ~~entered into fourth~~ and ~~fifth~~including ~~amendments (~~the ~~“Amendments”)~~ tofifth ~~its~~amendment ~~loan~~thereto, ~~and security agreement~~ dated as of ~~April~~February 2428, ~~2015 (as previously amended~~2018, provided that the ~~“Loan~~principal ~~Agreement”),~~repayment bydate ~~and~~in ~~among~~respect ~~Oxford Finance LLC, a Delaware limited liability company (“Oxford”), as collateral agent and one~~ of the ~~lenders, the lenders listed in the~~ Loan ~~Agreement~~was ~~and Lombard Medical Technologies Inc.~~April 1, ~~a Delaware corporation (“LM Technologies”) and Altura Medical, Inc~~2018., aThe ~~Delaware~~Company ~~corporation~~was ~~(“Altura”).~~unable ~~Both LM~~to ~~Technologies~~make ~~and~~the ~~Altura~~repayment ~~are subsidiaries~~ of ~~the~~principal ~~Company~~when ~~and~~due. ~~the~~Pursuant ~~“Borrowers”~~to ~~under~~ the ~~Loan~~terms ~~Agreement and the Company is a guarantor~~ of the ~~loan.~~Loan ~~The Amendments~~Agreement, ~~among~~Oxford ~~other~~Finance ~~things,~~was ~~extend~~entitled ~~the~~to ~~principal~~pursue ~~repayment date (along with~~ all ~~other~~ ~~payments~~ of its ~~interest~~available ~~and~~remedies ~~principal~~with ~~otherwise~~respect ~~due)~~ to ~~March 1~~the Loan, ~~2018~~including ~~(in~~foreclosing ~~respect~~on of the ~~fourth~~collateral ~~amendment)~~securing ~~and April 1, 2018 (in respect of~~ the ~~fifth amendment)~~Loan.

~~The~~On ~~foregoing~~April 24, ~~descriptions~~2018, ofthe Company, together with its primary subsidiaries, including the ~~Amendments~~Borrowers ~~does~~(collectively, ~~not~~the ~~purport~~“Lombard toGroup”) beentered ~~complete~~into an umbrella transaction deed (the “Transaction Deed”) with Oxford Finance and Endovascular Technology Corp., which is ~~qualified~~a insubsidiary ~~its~~of ~~entirety~~MicroPort byScientific ~~reference~~Corporation to(“MicroPort”). The Transaction Deed contemplates specified transactions (the ~~full~~“Transactions”), ~~text~~including the sale of the ~~Loan~~primary trading companies of the Lombard ~~Agreement~~Group, ~~and~~Lombard toMedical Limited, a company organized under the ~~Amendments~~laws of the United Kingdom, ~~copies~~and Lombard Medical Technologies GmbH, a company organized under the laws of ~~which~~Germany ~~are~~(together, ~~filed~~the ~~herewith~~“Trading asCompanies”), ~~Exhibits~~through ~~10.5~~an ~~and~~administration process 10under English law.6 The Transactions, ~~respectively.~~which had the consent of Oxford Finance, have been implemented by:

~~Creation~~• the commencement on April 24, 2018 of an official liquidation proceeding with respect to the Company under the laws of the Cayman Islands (the “Cayman Liquidation”) through a ~~Direct~~liquidator ~~Financial~~appointed ~~Obligation~~ by the Grand Court of the Cayman Islands; and

~~The~~• ~~information~~the ~~set~~entry ~~forth~~on ~~above~~April ~~regarding~~25, 2018 by Lombard Medical Technologies Limited (“LMTL”), a wholly owned subsidiary of the ~~Amendment~~Company isand ~~incorporated~~direct byparent ~~reference~~company ~~herein.~~of the Trading Companies, of an English law administration process under the Insolvency Act 1986.

~~Financial~~Pursuant ~~Statements~~to ~~and~~the ~~Exhibits~~Transactions:

~~See~~• ~~Exhibit~~LMTL, ~~Index~~while in administration, sold to MicroPort the entire issued share capital of the Trading Companies in exchange for $2,000,000 in cash, which amount will be used to partially repay amounts outstanding under the Loan;

~~-2-~~• the debt owed by Altura and LM Technologies to Oxford Finance was reduced by $15,000,000; and

•

the Company and LMTL received a full release from Oxford Finance in respect of all debt claims from Oxford Finance.

After giving effect to the Transactions, neither the Company nor LMTL has any meaningful assets. Accordingly, there will be no recovery for any unsecured creditor or equity holder of the Company in the Cayman Liquidation. Equity holders of a company in liquidation proceedings generally receive value only if all claims of a company’s secured and unsecured creditors are fully satisfied. The Company does not believe that the claims of its secured and unsecured creditors will be fully satisfied.

- 2 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

~~[Signature~~- ~~Page~~3 ~~to Form 6~~-K]

EXHIBIT INDEX

Exhibit		Description
10.1		Loan and Security Agreement, dated as of April 24, 2015, by and among Oxford Finance LLC, the lenders party thereto and Lombard Medical Technologies, Inc. (included as Exhibit 4.3 to our Registration Statement on Form F-3 filed on January 13, 2016 and incorporated herein by reference)
10.2		Consent and First Amendment to Loan Agreement, dated as of July 30, 2015, by and among Oxford Finance LLC, the lenders party thereto, Lombard Medical Technologies, Inc. and Altura Medical, Inc. (included as Exhibit 4.2 to our Registration Statement on Form F-3 filed on January 13, 2016 and incorporated herein by reference)
10.3		Second Amendment to Loan and Security Agreement, dated as of May 31, 2017, by and among Oxford Finance LLC, the lenders party thereto, Lombard Medical Technologies, Inc. and Altura Medical, Inc. (included as Exhibit 10.3 to our Report of Foreign Private Issuer on Form 6-K filed on October 19, 2017 and incorporated herein by reference)
10.4		Third Amendment to Loan and Security Agreement, dated as of October 13, 2017, by and among Oxford Finance LLC, the lenders party thereto, Lombard Medical Technologies, Inc. and Altura Medical, Inc. (included as Exhibit 10.4 to our Report of Foreign Private Issuer on Form 6-K filed on October 19, 2017 and incorporated herein by reference)
10.5		Fourth Amendment to Loan and Security Agreement, dated as of January 31, 2018, by and among Oxford Finance LLC, the lenders party thereto, Lombard Medical Technologies, Inc. and Altura Medical, Inc.
10.6		Fifth Amendment to Loan and Security Agreement, dated as of February 28, 2018, by and among Oxford Finance LLC, the lenders party thereto, Lombard Medical Technologies, Inc. and Altura Medical, Inc.

Lombard Medical, Inc.

Date: March 7, 2018

/s/ Kurt Lemvigh

Date: April 26, 2018

/s/ Kurt Lemvigh

Kurt Lemvigh

Chief Executive Officer

Filing Compare · Lombard Medical, Inc.